5UY-92281-83803
3 vaccinations
1 coded response
18 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 781 / TX
- Registered
- 2021-08-24
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-08-06
Dose 1 — Pfizer-BioNTech
-
2021-08-24
Registered in v-safe
- 2021-08-24
-
2021-08-27
Dose 2 — Pfizer-BioNTech
- 2021-08-27
-
2021-08-28
Survey response — days 1–6 daily, dose 2MedDRA: Dizziness — Feeling: Fair · Fatigue or tirednessFree text: DizzinessMedDRA releases: 2021-09,2024-11 · check-in free text available
- 2021-08-29
- 2021-08-30
- 2021-08-31
- 2021-09-01
- 2021-09-02
- 2021-09-03
- 2021-09-10
- 2021-09-17
- 2021-09-24
- 2021-10-01
- 2021-10-08
- 2021-11-26
- 2022-02-27
-
2022-03-09
Dose 3 — Pfizer-BioNTech
- 2022-08-27
- 2022-09-07
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-08-06 | Pfizer-BioNTech | No |
| 2 | 2021-08-27 | Pfizer-BioNTech | No |
| 3 | 2022-03-09 | Pfizer-BioNTech | No |
Free text
Release 9 — days 1–6 daily, dose 2
Systemic reaction (other): Dizziness
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Dizziness | ✓ | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release